Patient-centered collaboration for regimen optimization CAMBRIDGE, MA January 28, 2021 – Scipher Medicine, a precision immunology company matching patients with the most effective therapy, has joined the Massachusetts Institute of Technology Center for Biomedical Innovation’s … Read More

NEWDIGS Exutive Director Gigi Hirsch and Director of Research Kay Larholt were invited to participate in the National Academies of Science’s Envisioning a Transformed Clinical Trials Enterprise for 2030. This workshop is being … Read More

Collaboration to enhance the capacity of disease ecosystems for regimen optimization CAMBRIDGE, MA November 25, 2020 – Cerevel Therapeutics, a company dedicated to unraveling the mysteries of the brain to treat … Read More

NEW MEMBER NEWDIGS welcomes Cerevel Therapeutics as a new collaborator on the LEAPS Project Collaboration to enhance the capacity of disease ecosystems for regimen optimization Cerevel Therapeutics, a company dedicated … Read More

The LEAPS Project is advancing sustainable, patient-centered biomedical innovation through a new collaborative systems approach to the planning, production, and use of real-world evidence at the level of disease, not … Read More

RESEARCH SPOTLIGHT Downstream Innovation: Designing infrastructures and environments for real-world disease-focused learning The LEAPS Project is advancing sustainable, patient-centered biomedical innovation through a new collaborative systems approach to the planning, … Read More